Indian private equity firm Ascent Capital has invested INR1.25 billion ($17.5 million) in Naari Pharma, a women's health pharmaceutical business focused on hormonal generics.
Founded in 2016, Naari Pharma, formerly Indo Phyto Chemicals, is majority owned by Tenshi Life Sciences (TLS), a pharmaceutical holding company controlled by Arun Kumar, the chairman of Strides Pharma....
Abu Dhabi sovereign wealth fund Mubadala has agreed to invest INR90.9 billion ($1.2 billion) in Jio Platforms, the holding company for various internet and telecom assets owned by Indian oil-to-retail conglomerate Reliance Industries.
Bessemer Venture Partners has led an INR1.5 billion ($20 million) Series B round for teleconsultation health platform DocsApp.
Everest Medicines, a China-based biopharmaceutical company, has raised $310 million in Series C funding across two tranches.
Bespin Global, a Seoul and Beijing-based cloud management services provider, has raised RMB530 million ($74.6 million) in a Series C round from SK Telecom and existing investor DY Holdings.